Simplex Trading, LLC Lineage Cell Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,450 shares of LCTX stock, worth $725. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,450

Previous 2,855 49.21%

Holding current value

$725

Previous $2,000 50.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.8 - $1.12 $1,124 - $1,573	-1,405 Reduced 49.21%	1,450 $1,000
Q2 2024 Jul 25, 2024	SELL	$0.89 - $1.47 $3,065 - $5,062	-3,444 Reduced 54.68%	2,855 $2,000
Q1 2024 Apr 25, 2024	SELL	$0.86 - $1.48 $2,801 - $4,820	-3,257 Reduced 34.08%	6,299 $9,000
Q4 2023 Feb 02, 2024	BUY	$0.91 - $1.35 $7,485 - $11,105	8,226 Added 618.5%	9,556 $10,000
Q3 2023 Nov 01, 2023	SELL	$1.16 - $1.53 $61 - $81	-53 Reduced 3.83%	1,330 $1,000
Q2 2023 Aug 04, 2023	BUY	$1.26 - $1.53 $1,742 - $2,115	1,383 New	1,383 $1,000
Q2 2022 Aug 03, 2022	SELL	$1.12 - $1.61 $4,631 - $6,657	-4,135 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.21 - $2.48 $2,332 - $4,781	-1,928 Reduced 31.8%	4,135 $6,000
Q4 2021 Feb 23, 2022	SELL	$1.84 - $2.68 $83,388 - $121,457	-45,320 Reduced 88.2%	6,063 $14,000
Q2 2021 Aug 12, 2021	SELL	$2.17 - $3.0 $43,892 - $60,681	-20,227 Reduced 28.25%	51,383 $146,000
Q1 2021 Apr 26, 2021	BUY	$1.77 - $3.1 $126,749 - $221,991	71,610 New	71,610 $168,000
Q4 2020 Feb 02, 2021	SELL	$0.95 - $1.83 $12,363 - $23,815	-13,014 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$0.75 - $1.09 $225 - $327	-300 Reduced 2.25%	13,014 $12,000
Q2 2020 Jul 13, 2020	BUY	$0.71 - $1.18 $9,452 - $15,710	13,314 New	13,314 $11,000
Q1 2020 Apr 29, 2020	SELL	$0.6 - $1.58 $51 - $134	-85 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$0.54 - $1.01 $6 - $12	12 Added 16.44%	85 $0
Q3 2019 Oct 15, 2019	BUY	$0.85 - $1.24 $62 - $90	73 New	73 $0

Others Institutions Holding LCTX

# of Institutions

121

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Lineage Cell Therapeutics, Inc. Transaction History